EP3503911A4 - Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same - Google Patents

Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same Download PDF

Info

Publication number: EP3503911A4
Authority: EP; European Patent Office
Prior art keywords: analogs; albumin; making; methods; same
Prior art date: 2016-08-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP17844067.3A

Other languages

German (de)

French (fr)

Other versions

EP3503911A1 (en

Inventor

Joseph Y. Mo

Chun Kwong Chu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nal Pharmaceutical Group Ltd

Original Assignee

Nal Pharmaceutical Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-08-26

Filing date

2017-06-27

Publication date

2020-07-29

2016-08-26 Priority claimed from US15/249,346 external-priority patent/US20170002057A1/en

2017-06-27 Application filed by Nal Pharmaceutical Group Ltd filed Critical Nal Pharmaceutical Group Ltd

2019-07-03 Publication of EP3503911A1 publication Critical patent/EP3503911A1/en

2020-07-29 Publication of EP3503911A4 publication Critical patent/EP3503911A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

EP17844067.3A 2016-08-26 2017-06-27 Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same Withdrawn EP3503911A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15/249,346 US20170002057A1 (en)	2015-02-26	2016-08-26	Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same
PCT/US2017/039477 WO2018038803A1 (en)	2016-08-26	2017-06-27	Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same

Publications (2)

Publication Number	Publication Date
EP3503911A1 EP3503911A1 (en)	2019-07-03
EP3503911A4 true EP3503911A4 (en)	2020-07-29

Family

ID=61247532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17844067.3A Withdrawn EP3503911A4 (en)	2016-08-26	2017-06-27	Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same

Country Status (4)

Country	Link
EP (1)	EP3503911A4 (en)
JP (1)	JP2019534707A (en)
SG (1)	SG11201901651TA (en)
WO (1)	WO2018038803A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2020175935A1 (en) *	2019-02-27	2020-09-03	주식회사 대웅제약	Albumin-bound composition including lrrd2 of slit3 protein for prevention or treatment of bone-related diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102391376A (en) *	2011-03-15	2012-03-28	江苏省原子医学研究所	Fusion protein of human somatostatin tetradecapeptide and human serum albumin, and coding gene and preparation method thereof
CN102675467A (en) *	2011-03-15	2012-09-19	无锡坤洲大得药业有限公司	Fusion protein of human somatostatin 28 peptide and human serum albumin, encoding gene of fusion protein and preparation method for fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4599229A (en) *	1985-09-09	1986-07-08	International Minerals & Chemical Corp.	Method of promoting animal growth using antibodies against somatostatin
EP1463752A4 (en) *	2001-12-21	2005-07-13	Human Genome Sciences Inc	Albumin fusion proteins
CA2728735A1 (en) *	2008-06-25	2009-12-30	Braasch Biotech Llc	Compositions and methods for enhanced somatostatin immunogenicity
US20170002057A1 (en) *	2015-02-26	2017-01-05	Nal Pharmaceutical Group Limited	Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same

2017
- 2017-06-27 JP JP2019531852A patent/JP2019534707A/en active Pending
- 2017-06-27 SG SG11201901651TA patent/SG11201901651TA/en unknown
- 2017-06-27 WO PCT/US2017/039477 patent/WO2018038803A1/en unknown
- 2017-06-27 EP EP17844067.3A patent/EP3503911A4/en not_active Withdrawn

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102391376A (en) *	2011-03-15	2012-03-28	江苏省原子医学研究所	Fusion protein of human somatostatin tetradecapeptide and human serum albumin, and coding gene and preparation method thereof
CN102675467A (en) *	2011-03-15	2012-09-19	无锡坤洲大得药业有限公司	Fusion protein of human somatostatin 28 peptide and human serum albumin, encoding gene of fusion protein and preparation method for fusion protein

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DING Y ET AL: "The effect of albumin fusion patterns on the production and bioactivity of the somatostatin-14 fusion protein in Pichia pastoris", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY AUGUST 2013 HUMANA PRESS USA, vol. 170, no. 7, August 2013 (2013-08-01), pages 1637 - 1648, XP002797314, DOI: 10.1007/S12010-013-0304-1 *
DING YUEDI ET AL: "The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein inPichia pastoris", JOURNAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, BASINGSTOKE, GB, vol. 41, no. 6, 22 April 2014 (2014-04-22), pages 997 - 1006, XP035318227, ISSN: 1367-5435, [retrieved on 20140422], DOI: 10.1007/S10295-014-1440-5 *
See also references of WO2018038803A1 *

Also Published As

Publication number	Publication date
EP3503911A1 (en)	2019-07-03
WO2018038803A1 (en)	2018-03-01
SG11201901651TA (en)	2019-03-28
JP2019534707A (en)	2019-12-05

Publication	Publication Date	Title
EP3802812A4 (en)	2022-03-30	Rna-targeting fusion protein compositions and methods for use
IL250622B (en)	2022-12-01	Sirp-alpha immunoglobulin fusion proteins, their preparation and pharmaceutical compositions containing them
IL260530B1 (en)	2023-09-01	Multivalent and multispecific 41bb-binding fusion proteins, compositions ocmprising same and uses thereof
EP3880814A4 (en)	2022-09-21	Fusion protein
EP3454832A4 (en)	2019-12-18	Gdf15 fusion proteins and uses thereof
EP3430058A4 (en)	2019-10-23	Multispecific fab fusion proteins and use thereof
EP3481413A4 (en)	2020-01-08	Fusion protein comprising leptin and methods for producing and using the same
EP3155018A4 (en)	2018-01-10	Constant region antibody fusion proteins and compositions thereof
EP3665194A4 (en)	2021-07-07	Affinity-based methods for using transferrin receptor-binding proteins
EP3274457A4 (en)	2018-08-08	Follistatin-related fusion proteins and uses thereof
EP3500112A4 (en)	2020-02-12	Brewer's spent-grain based protein powder
EP3757218A4 (en)	2021-11-24	Fusion protein
EP3315515A4 (en)	2019-06-05	Fusion protein containing bdnf
EP3561058A4 (en)	2020-07-22	Fusion protein including bdnf
EP3431506A4 (en)	2020-01-22	Multi-functional fusion polypeptide, preparation method thereof, and application of same
IL275435A (en)	2020-08-31	Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
EP3253797A4 (en)	2018-10-03	Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
ZA202007491B (en)	2022-09-28	Stable fusion protein formulation
IL263842A (en)	2019-01-31	Tatk -cdkl5 fusion proteins, compositions, formulations, and use thereof
EP3257523A4 (en)	2018-04-04	Use of polypeptide complex as polypeptide or protein drug carrier, method, and fusion protein complex thereof
EP3464384A4 (en)	2020-03-25	Fusion protein construct
EP3400228A4 (en)	2019-08-14	Fused quadracyclic compounds, compositions and uses thereof
EP3319930A4 (en)	2019-04-10	Methods and compositions for the stabilizaton of proteins
EP3647426A4 (en)	2021-04-14	Fusion protein
EP3503911A4 (en)	2020-07-29	Compositions containing fusion protein of albumin and analogs thereof, methods for making and using the same

Legal Events

Date	Code	Title	Description
2018-03-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-05-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-05-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-07-03	17P	Request for examination filed	Effective date: 20190325
2019-07-03	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-07-03	AX	Request for extension of the european patent	Extension state: BA ME
2019-12-04	DAV	Request for validation of the european patent (deleted)
2019-12-04	DAX	Request for extension of the european patent (deleted)
2020-03-11	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 5/02 20060101ALI20200204BHEP Ipc: C07K 14/765 20060101ALI20200204BHEP Ipc: A61K 38/38 20060101ALI20200204BHEP Ipc: A61K 38/22 20060101ALI20200204BHEP Ipc: A61K 38/31 20060101AFI20200204BHEP Ipc: C07K 14/655 20060101ALI20200204BHEP Ipc: A61K 38/16 20060101ALI20200204BHEP Ipc: C12N 15/62 20060101ALI20200204BHEP
2020-07-03	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 40010491 Country of ref document: HK
2020-07-29	A4	Supplementary search report drawn up and despatched	Effective date: 20200626
2020-07-29	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/22 20060101ALI20200622BHEP Ipc: C07K 14/655 20060101ALI20200622BHEP Ipc: A61K 38/31 20060101AFI20200622BHEP Ipc: A61K 38/16 20060101ALI20200622BHEP Ipc: C12N 15/62 20060101ALI20200622BHEP Ipc: A61P 5/02 20060101ALI20200622BHEP Ipc: A61K 38/38 20060101ALI20200622BHEP Ipc: C07K 14/765 20060101ALI20200622BHEP
2022-04-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2022-06-01	18D	Application deemed to be withdrawn	Effective date: 20220104